# American Society of Nephrology

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/american-society-of-nephrology/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | organization |
| OpenAlex ID | https://openalex.org/F4320306605 |
| ROR ID | https://ror.org/014pcm848 |
| Works | 3,651 |

## Funder papers

- [Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases](https://scholariq.org/papers/executive-summary-of-the-kdigo-2021-guideline-for-the-management-of-glomerular/)
- [Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial](https://scholariq.org/papers/empagliflozin-and-kidney-function-decline-in-patients-with-type-2-diabetes-a/)
- [KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)](https://scholariq.org/papers/kdigo-2025-clinical-practice-guideline-for-the-management-of-immunoglobulin-a/)
- [Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy](https://scholariq.org/papers/mycophenolate-mofetil-in-combination-with-steroids-for-treatment-of-c3/)
- [Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial](https://scholariq.org/papers/effects-of-empagliflozin-on-progression-of-chronic-kidney-disease-a-prespecified/)
- [Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKD](https://scholariq.org/papers/correlates-and-consequences-of-an-acute-change-in-egfr-in-response-to-the-sglt2/)
- [Effect of semaglutide on kidney function across different levels of baseline HbA1c, blood pressure, body weight and albuminuria in SUSTAIN 6 and PIONEER 6](https://scholariq.org/papers/effect-of-semaglutide-on-kidney-function-across-different-levels-of-baseline/)
- [Sensitivity and Specificity of Transferrin Saturation and Serum Ferritin as Markers of Iron Status After Intravenous Iron Dextran in Hemodialysis Patients](https://scholariq.org/papers/sensitivity-and-specificity-of-transferrin-saturation-and-serum-ferritin-as/)
- [Patients with Idiopathic Membranous Nephropathy: A Real-World Clinical and Economic Analysis of U.S. Claims Data](https://scholariq.org/papers/patients-with-idiopathic-membranous-nephropathy-a-real-world-clinical-and/)
- [Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes and CKD](https://scholariq.org/papers/efficacy-and-safety-of-sotagliflozin-in-patients-with-type-1-diabetes-and-ckd/)
- [Clinical characteristics and disease outcomes in non-diabetic chronic kidney disease: retrospective analysis of a US healthcare claims database](https://scholariq.org/papers/clinical-characteristics-and-disease-outcomes-in-non-diabetic-chronic-kidney/)
- [Long-term renal survival in patients with IgA nephropathy: a systematic review](https://scholariq.org/papers/long-term-renal-survival-in-patients-with-iga-nephropathy-a-systematic-review/)
- [Patient-Reported Outcomes Measures, Polycystic Kidney Disease Burden, and Outcomes in Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/patient-reported-outcomes-measures-polycystic-kidney-disease-burden-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.